Ribavirin and use of clotting factors in patients with hemophilia and chronic hepatitis C [4]

JAMA

Volumn 293, Issue 10, 2005, Pages 1190-1192

  Honda, Takashi ^a   Toyoda, Hidenori ^a   Hayashi, Kazuhiko ^a   Katano, Yoshiaki ^a   Yano, Motoyoshi ^a   Nakano, Isao ^a   Yoshioka, Kentaro ^a   Goto, Hidemi ^a   Yamamoto, Koji ^a   Takamatsu, Junki ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BLOOD CLOTTING FACTOR; RIBAVIRIN; ANTIVIRUS AGENT; INTERFERON;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ERADICATION THERAPY; HEMOGLOBIN DETERMINATION; HEMOLYTIC ANEMIA; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HEPATITIS C; HUMAN; LETTER; MALE; MONOTHERAPY; OUTPATIENT CARE; PRIORITY JOURNAL; MIDDLE AGED;

ADULT; ANTIVIRAL AGENTS; BLOOD COAGULATION FACTORS; HEMOPHILIA A; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; MALE; MIDDLE AGED; RIBAVIRIN;

EID: 14544290531     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. McHutchison JG, Gordon SC, Schiff ER, et al; Hepatitis Interventional Therapy Group. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med. 1998;339:1485-1492.
2. Poynard T, Marcellin P, Lee SS, et al; International Hepatitis Interventional Therapy Group (IHIT). Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet. 1998;352:1426-1432.
3. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001;358:958-965.
4. Santagostino E, Rumi MG, Rivi M, Colombo M, Mannucci PM. Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapy. Blood. 2002;99:1089-1091.
5. Fried MW, Peter J, Hoots K, et al. Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirin. Hepatology. 2002;36:967-972.
6. Schulman S. Inhibition of warfarin activity by ribavirin. Ann Pharmacother. 2002;36:72-74.